Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Imaging of the metabotropic glutamate receptor (mGluR5) abnormalities in patients with bilateral focal or neocortical epilepsy

FY 2019-20

Summary
"Epilepsy is a neurological condition characterized by recurrent seizures. If those with epilepsy do not respond to anti-seizure medication, surgical treatment may be an option. Successful brain surgery prevents seizures in as many as 90% of operated patients. To achieve that rate of success, patients with a type of epilepsy called temporal lobe epilepsy (TLE) usually undergo a comprehensive evaluation. Nevertheless, many TLE patients still cannot have their seizure focus precisely localized. In our study, we will further evaluate the value of a new non-invasive brain imaging scan that looks at a specific receptor previously shown to be abnormal in brain regions that generate seizures. The receptor that we are examining is called metabotropic glutamate receptor type 5 (mGluR5) and it modulates excitability through glutamate. The availability of mGluR5 in the brain can be imaged in vivo by positron emission tomography (PET). Previous studies from our laboratory have demonstrated that mGluR5 PET scans precisely localize the focus in TLE patients with a well-defined unilateral generator of seizures. It remains to be learned if it could be clinically useful for patients who do not always get offered a surgical treatment. Here, we will apply mGluR5 PET imaging to determine whether its specificity for the focus can localize the abnormalities in patients with a suspected bilateral seizure focus or those that affect the neocortical aspects of the temporal lobes. This project has the potential to validate a non-invasive method to localize the focus and to determine surgical candidacy in a broader way. In the long term, this project will also help pave the way for future research that examines and targets glutamatergic neurotransmission to control seizures."
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
428896
Name
Kermani Koosheh Siavash
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Imaging of the metabotropic glutamate receptor (mGluR5) abnormalities in patients with bilateral focal or neocortical epilepsy
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Abp688; Bilateral Temporal; Epilepsy; Metabotropic Glutamate Receptor; Mglur5; Neocortical; Neuroimaging; Neurophysiology; Positron Emission Topography
Abstract
"Epilepsy is a neurological condition characterized by recurrent seizures. If those with epilepsy do not respond to anti-seizure medication, surgical treatment may be an option. Successful brain surgery prevents seizures in as many as 90% of operated patients. To achieve that rate of success, patients with a type of epilepsy called temporal lobe epilepsy (TLE) usually undergo a comprehensive evaluation. Nevertheless, many TLE patients still cannot have their seizure focus precisely localized. In our study, we will further evaluate the value of a new non-invasive brain imaging scan that looks at a specific receptor previously shown to be abnormal in brain regions that generate seizures. The receptor that we are examining is called metabotropic glutamate receptor type 5 (mGluR5) and it modulates excitability through glutamate. The availability of mGluR5 in the brain can be imaged in vivo by positron emission tomography (PET). Previous studies from our laboratory have demonstrated that mGluR5 PET scans precisely localize the focus in TLE patients with a well-defined unilateral generator of seizures. It remains to be learned if it could be clinically useful for patients who do not always get offered a surgical treatment. Here, we will apply mGluR5 PET imaging to determine whether its specificity for the focus can localize the abnormalities in patients with a suspected bilateral seizure focus or those that affect the neocortical aspects of the temporal lobes. This project has the potential to validate a non-invasive method to localize the focus and to determine surgical candidacy in a broader way. In the long term, this project will also help pave the way for future research that examines and targets glutamatergic neurotransmission to control seizures."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kermani Koosheh, Siavash
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~